💊
Rasagiline Viatris (previously Rasagiline Mylan)
rasagiline
Parkinson Disease
✅ Authorised
Generic
✅
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Rasagiline Viatris is indicated for the treatment of idiopathic Parkinson’s disease (PD) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
⚠️ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/rasagiline-viatris